Episode Details

Back to Episodes

A blueprint for investing in biotech

Episode 692 Published 6 years, 10 months ago
Description

If we take anything away from this week's headlines surrounding Biogen, it should be this: The biotech space is volatile in nature. It's common for multibillion-dollar titans in the space to move 30% or more in either direction. In today's educational segment, I break down a simple strategy for finding ideas in biotech… and ensuring the reward is worth the risk [39:11].


But first… Brent Johnson, CEO of Santiago Capital, tells us why he believes both the dollar and gold will move higher. And he offers a bold prediction on the direction of U.S. stocks over the coming months [13:32].

--------------------------------

Enjoyed this episode?

 

Get Wall Street Unplugged delivered FREE to your inbox every Wednesday: https://www.curzioresearch.com/wall-street-unplugged/

 

--------------------------------

 

Wall Street Unplugged podcast is available at:

--iTunes: https://itunes.apple.com/us/podcast/wall-street-unplugged-frank/

--Stitcher: https://www.stitcher.com/podcast/curzio-research/wall-street-unplugged-2

--Website: https://www.curzioresearch.com/category/podcast/wall-street-unplugged/

 

Twitter: https://twitter.com/frankcurzio

Facebook:. https://www.facebook.com/CurzioResearch/

Linkedin: https://www.linkedin.com/in/frank-curzio-690561a7/

Website: https://www.curzioresearch.com

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us